An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol
Clinical trial NCT05874336 · COMPLETED
Trial details
- NCT number
- NCT05874336
- Sponsor
- Galmed Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-08-11
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.